(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TRUEMAB

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

TRUEMAB

ST13

US500000085203359

Class

1

Filing

85203359

Registration

4166501

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

41

Latest update

12/30/2021

Trademark type

Combined

Nice classes

1

Filing date

12/21/2010

Registration date

07/03/2012

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/30/2021

Last transaction

12/30/2021

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

04/30/2010

First use in commerce

04/30/2010

Drawing code

3

Owner type

03

Owner location

Rockville, MD, US

Examiner

MUNN LEWIS, LAKEISHA S

Law office

M20

Current location

GENERIC WEB UPDATE

Mark description

The mark consists of the wording "TRUEMAB" and design of an antibody.

Holders and representatives

Holders

Origene Technologies, Inc.

Representatives

Jeffrey R. Cohen Millen, White, Zelano & Branigan, P.C.

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

monoclonal antibodies for in vitro scientific or research use

Publications

History of USPTO decisions and trademark events.

41 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

12/30/2021

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

12/30/2021

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

12/30/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/30/2021

E89R

TEAS SECTION 8 & 9 RECEIVED

07/21/2021

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

07/03/2021

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

07/16/2018

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

07/16/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/16/2018

E815

TEAS SECTION 8 & 15 RECEIVED

07/03/2018

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/03/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

07/03/2012

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/17/2012

PUBO

PUBLISHED FOR OPPOSITION

04/17/2012

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/28/2012

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/13/2012

ALIE

ASSIGNED TO LIE

03/11/2012

ALIE

ASSIGNED TO LIE

03/10/2012

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/24/2012

XAEC

EXAMINER'S AMENDMENT ENTERED

02/24/2012

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/24/2012

GNEA

EXAMINERS AMENDMENT E-MAILED

02/24/2012

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/24/2012

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/23/2012

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/23/2012

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/26/2012

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/25/2012

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

01/25/2012

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

11/03/2011

GNFR

FINAL REFUSAL E-MAILED

11/03/2011

CNFR

FINAL REFUSAL WRITTEN

11/03/2011

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/21/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/21/2011

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/21/2011

GPRN

NOTIFICATION OF PRIORITY ACTION E-MAILED

03/21/2011

GPRA

PRIORITY ACTION E-MAILED

03/21/2011

CPRA

PRIORITY ACTION WRITTEN

03/21/2011

DOCK

ASSIGNED TO EXAMINER

03/21/2011

MDSM

NOTICE OF DESIGN SEARCH CODE MAILED

12/31/2010

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/30/2010

NWAP

NEW APPLICATION ENTERED

12/24/2010

Continuous trademark protection

Get notified about every new filing that threatens TRUEMAB or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.